Medication info
Telmisartan/Amlodipine Tablet 40/5mg

Telmisartan/Amlodipine Tablet 40/5mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
GL Pharma Co., Ltd.
Appearance
White or off-white oblong tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201903386 · Approved 2019.05.24 · Insurance code 649702210

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not adequately controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or above, amlodipine clearance is reduced; therefore, start treatment at a lower dose and increase the dose gradually.
Child dose
Use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
GL Pharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of amlodipine or telmisartan. It helps to effectively lower blood pressure and reduce the risk of cardiovascular diseases.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not adequately controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or above, amlodipine clearance is reduced; therefore, start treatment at a lower dose and increase the dose gradually.

Child dose

Use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it may cause serious harm to the fetus. There is an increased risk of fetal kidney dysfunction, decreased amniotic fluid, and cranial formation abnormalities. If pregnancy is confirmed, this medication should be discontinued immediately. This medication is contraindicated for individuals with allergies to the active or similar ingredients, pregnant or potentially pregnant women, nursing mothers, and patients with severe liver or biliary problems. Additionally, it should not be administered to patients with severely impaired heart function, those with very low blood pressure, or patients in an unstable condition after acute myocardial infarction. Caution is required when using this medication in patients with primary aldosteronism, certain valvular heart diseases, liver disorders, gastrointestinal disorders, renal artery stenosis, dialysis patients, and the elderly. In particular, patients with impaired liver function may require dose adjustments. Common side effects while taking this medication include dizziness and peripheral edema, and rarely, serious side effects such as syncope may occur. Hypotension symptoms such as excessively low blood pressure may arise; hence patients with fluid or salt deficiency should correct these deficiencies before taking the medication or adjust the dose under medical supervision. Blood potassium levels may increase; therefore, patients, especially those with renal disease or heart failure, should regularly monitor potassium levels through blood tests. This medication may affect kidney function; therefore, patients with weak kidney function need regular blood and kidney function tests. Patients with heart disease should be careful, as too low blood pressure can worsen myocardial infarction or angina pectoris. Dizziness or drowsiness may occur while driving or operating machinery; caution is advised. There may be drug interactions when taken with other medications, so consult healthcare professionals, particularly when taking digoxin, lithium, warfarin, non-steroidal anti-inflammatory drugs, grapefruit juice, etc. Taking this medication during pregnancy can pose serious risks to the fetus, so individuals planning for pregnancy or who are already pregnant should consult with healthcare professionals, and nursing mothers should also avoid taking this medication. Safety and effectiveness in children under 18 have not been sufficiently established, so use in this population is not recommended. When administered to the elderly, as they may be more sensitive in their bodily reactions, starting with a lower dose and gradually increasing is advisable. In case of overdose, symptoms such as low blood pressure, dizziness, and cardiac function decline may occur, necessitating immediate emergency treatment, as this medication is not removed by hemodialysis. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • shortness of breath
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug eruption
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • phototoxic reaction
  • joint swelling
  • muscle cramp
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal impairment
  • acute renal failure
  • urinary disorders
  • frequent urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a dark container protected from light. Additionally, it is important to store it at room temperature, specifically between 1 degree and 30 degrees Celsius, to maintain its efficacy.

Appearance and packaging

Appearance

White or off-white oblong tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.